TRIALNET: Type 1 Diabetes TrialNet

General Public About TrialNet Studies Joining TrialNet Studies Health Care Professionals Research Collaborators Media Type 1 Diabetes TrialNet

Welcome To TrialNet

TrialNet is a network of 18 Clinical Centers working in cooperation with screening sites throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia, and New Zealand. This network is dedicated to the study, prevention, and early treatment of type 1 diabetes. TrialNet is supported by the United States National Institutes of Health and Department of Health & Human Services, Juvenile Diabetes Research Foundation International, and the American Diabetes Association.

This website is maintained by the George Washington University, Biostatistics Center, which coordinates the TrialNet Studies in cooperation with the University of Miami.

News

More information about TrialNet

NEW! video to help you understand what the Natural History Study is all about. This video is for persons interested in joining this study. The information presented is consistent with that provided in the informed consent process. (Flash plug-in required.)

Animated movies with more information about what TrialNet is and which studies are currently recruiting. (Flash plug-in required.)

TrialNet Launches New Studies

CTLA-4 Ig (Abatacept) in Recent Onset Diabetes (New!)
NIH/NIDDK Press Release - January 31, 2007
Study to test Oral Insulin to Prevent Type 1 Diabetes (Oral Insulin Study Brochure)
Study of Newborns at Risk of Type 1 Diabetes(NIP Brochure) (Enrollment Completed February 2008)
Studies for Newly Diagnosed Type 1 Diabetes
- The Rituximab Study (Enrollment Completed July 2007)
- MMF/DZB (Enrollment Completed January 2007)
- Type 1 Diabetes TrialNet is preparing to launch several new studies in early 2008 for people newly diagnosed with type 1 diabetes. The group is also collaborating with the Immune Tolerance Network, also funded by NIH, to perform studies aimed at the protection of beta cells in people recently diagnosed with type 1 diabetes. Please check this website for future updates.